Cargando…
Randomized Clinical Trial on Ivermectin versus Thiabendazole for the Treatment of Strongyloidiasis
BACKGROUND: Strongyloidiasis may cause a life-threatening disease in immunosuppressed patients. This can only be prevented by effective cure of chronic infections. Direct parasitologic exams are not sensitive enough to prove cure if negative. We used an indirect immune fluorescent antibody test (IFA...
Autores principales: | Bisoffi, Zeno, Buonfrate, Dora, Angheben, Andrea, Boscolo, Marina, Anselmi, Mariella, Marocco, Stefania, Monteiro, Geraldo, Gobbo, Maria, Bisoffi, Giulia, Gobbi, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144183/ https://www.ncbi.nlm.nih.gov/pubmed/21814588 http://dx.doi.org/10.1371/journal.pntd.0001254 |
Ejemplares similares
-
Progress towards the implementation of control programmes for strongyloidiasis in endemic areas: estimation of number of adults in need of ivermectin for strongyloidiasis
por: Buonfrate, Dora, et al.
Publicado: (2024) -
Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy
por: Gobbi, Federico, et al.
Publicado: (2019) -
Severe strongyloidiasis: a systematic review of case reports
por: Buonfrate, Dora, et al.
Publicado: (2013) -
Preventive chemotherapy for the control of strongyloidiasis in school-age children: Estimating the ivermectin need
por: Bisanzio, Donal, et al.
Publicado: (2021) -
Profile of Trypanosoma cruzi Infection in a Tropical Medicine Reference Center, Northern Italy
por: Gobbi, Federico, et al.
Publicado: (2014)